A detailed history of Lm Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lm Advisors LLC holds 4,884 shares of LLY stock, worth $3.68 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
4,884
Previous 4,994 2.2%
Holding current value
$3.68 Million
Previous $4.52 Million 4.29%
% of portfolio
0.88%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $84,935 - $105,602
-110 Reduced 2.2%
4,884 $4.33 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $236,307 - $296,347
-326 Reduced 6.13%
4,994 $4.52 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $28,425 - $38,029
-48 Reduced 0.89%
5,320 $4.14 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $2.82 Million - $3.32 Million
5,368 New
5,368 $3.13 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lm Advisors LLC Portfolio

Follow Lm Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lm Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lm Advisors LLC with notifications on news.